Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua N Goldstein

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Andexanet alfa, an antidote for uncontrollable bleeding after treatment with rivaroxaban or apixabanJoshua N Goldstein
Neurocritical Care|September 16, 2017
Emergency Neurological Life Support: Status EpilepticusJan Claassen, Joshua N Goldstein
Emergency Medicine Clinics of North America|October 16, 2016
Diagnosis and Management of Acute Intracerebral HemorrhageAndrea Morotti, Joshua N Goldstein
Current Neurology and Neuroscience Reports|June 28, 2014
Emergency reversal of anticoagulation: novel agentsMichael Levine, Joshua N Goldstein
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 27, 2015
Exception from informed consent: ethics and logisticsJoshua N Goldstein, Rongwei Fu
Hematology. American Society of Hematology. Education Program|February 20, 2015
Bleeding complications of targeted oral anticoagulants: what is the risk?Michael Levine, Joshua N Goldstein
Journal of the American Heart Association|July 21, 2022
Neurological Deterioration in Intracerebral Hemorrhage: Can We Predict It, and What Would We Do If We Could?Qi Li, Joshua N Goldstein
Current Treatment Options in Neurology|October 4, 2016
New Oral Anticoagulants and Their Reversal AgentsAndrea Morotti, Joshua N Goldstein
Emergency Medicine Clinics of North America|February 17, 2009
Rapid focused neurological assessment in the emergency department and ICUJoshua N Goldstein, David M Greer
Cleveland Clinic Journal of Medicine|November 5, 2010
Should anticoagulation be resumed after intracerebral hemorrhage?Joshua N Goldstein, Steven M Greenberg
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Andexanet alfa, an antidote for uncontrollable bleeding after treatment with rivaroxaban or apixabanJoshua N Goldstein
Neurocritical Care|September 16, 2017
Emergency Neurological Life Support: Status EpilepticusJan Claassen, Joshua N Goldstein
Emergency Medicine Clinics of North America|October 16, 2016
Diagnosis and Management of Acute Intracerebral HemorrhageAndrea Morotti, Joshua N Goldstein
Current Neurology and Neuroscience Reports|June 28, 2014
Emergency reversal of anticoagulation: novel agentsMichael Levine, Joshua N Goldstein
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 27, 2015
Exception from informed consent: ethics and logisticsJoshua N Goldstein, Rongwei Fu
Hematology. American Society of Hematology. Education Program|February 20, 2015
Bleeding complications of targeted oral anticoagulants: what is the risk?Michael Levine, Joshua N Goldstein
Journal of the American Heart Association|July 21, 2022
Neurological Deterioration in Intracerebral Hemorrhage: Can We Predict It, and What Would We Do If We Could?Qi Li, Joshua N Goldstein
Current Treatment Options in Neurology|October 4, 2016
New Oral Anticoagulants and Their Reversal AgentsAndrea Morotti, Joshua N Goldstein
Emergency Medicine Clinics of North America|February 17, 2009
Rapid focused neurological assessment in the emergency department and ICUJoshua N Goldstein, David M Greer
Cleveland Clinic Journal of Medicine|November 5, 2010
Should anticoagulation be resumed after intracerebral hemorrhage?Joshua N Goldstein, Steven M Greenberg
Pageof 25